On Mar. 31, 2022, researchers in Brazil reported that a study of COVID-19 patients at 12 clinics that used ivermectinﾗan antiparasitic drugﾗdidn’t prevent hospital admission compared with those in the placebo group.

The findings were published its findings in the New England Journal of Medicine.